Hudson Bay Capital Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Hudson Bay Capital Management’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-450,000	Closed	-$4.87M	–	1002
2023 Q3	$4.87M	Hold	450,000	–	–	0.04%	295
2023 Q2	$4.79M	Buy	450,000 +200,000	+80%	+$2.1M	0.03%	314
2023 Q1	$2.61M	Hold	250,000	–	–	0.02%	475
2022 Q4	$2.57M	Hold	250,000	–	–	0.03%	543
2022 Q3	$2.51M	Hold	250,000	–	–	0.02%	667
2022 Q2	$2.51M	Hold	250,000	–	–	0.02%	713
2022 Q1	$2.47M	Buy	+250,000	New	+$2.47M	0.03%	646

Hudson Bay Capital Management's BIOS Position: Q4 2023 in Review

Hudson Bay Capital Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 450,000 shares — an estimated $4.87M sold.

Hudson Bay Capital Management first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $4.87M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

Hudson Bay Capital Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Hudson Bay Capital Management sold 450,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $4.87M.
Hudson Bay Capital Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
Hudson Bay Capital Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $4.87M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.